Description

This specialized research formulation combines three potent compounds—Dihexa, Tesofensine, and BPC-157—into a single oral tablet designed for advanced experimental applications. Each compound is being studied in preclinical environments for its unique effects on neurological function, metabolic activity, and tissue regeneration. This synergistic blend offers a novel approach to exploring multi-target research hypotheses.

Blend Composition (Per Tablet):

• Dihexa – 10mg
• Tesofensine – 0.25mg
• BPC-157 – 0.125mg
• 60 tablets per bottle

Key Characteristics:

• Dihexa: Experimental nootropic peptide studied for synaptogenic activity
• Tesofensine: Dopamine-norepinephrine-serotonin reuptake inhibitor explored for metabolic and cognitive outcomes
• BPC-157: Synthetic pentadecapeptide fragment studied in regenerative and anti-inflammatory models
• Oral format with high bioavailability potential in animal studies
• Manufactured under strict research-grade conditions

Intended Use:
This product is intended strictly for laboratory research research use only. It is not intended for human consumption, therapeutic use, or diagnostic procedures. Any off-label use is strictly prohibited.